The risk of leaving multidrug-resistant tuberculosis untreated.
若不治疗耐多药结核病的危险。
There were an estimated 0.5 million cases of multidrug-resistant TB (MDR-TB) in 2006.
在2006年，估计有50万例耐多药结核病例。
There were an estimated 0.5 million cases of multidrug-resistant TB (MDR-TB) in 2007.
2007年，耐多药结核病例估计数为50万例。
Prevention and control of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis.
预防和控制耐多药结核病和广泛耐药结核病。
Detection of multidrug resistance-related genes and proteins.
多药耐药相关基因与蛋白的检测。
About 440 000 new cases of multidrug-resistant tuberculosis (MDR-TB) emerge annually, causing at least 150 000 deaths.
每年出现约44万耐多药结核病(MDR - TB)新发病例，至少造成15万例死亡。
Objective: to study the induction of apoptosis and explore the mechanism of multidrug resistance of human bladder cancer.
目的：研究阿霉素诱导的细胞凋亡，探讨人膀胱癌多重抗药性机制。
Purpose:To illustrate anti P gp monoclonal antibody(JSB 1) can reverse multidrug resistance(MDR) of the human kidney cancer.
目的：证实抗P糖蛋白单克隆抗体（JSB1 ）能逆转人肾癌的天然多药耐药（MDR）性。
Seven patients had turned up with multidrug-resistant tuberculosis; four had been cured, two had died - and one had simply disappeared.
曾经有七名耐多药结核病患者，四人病愈，两人死亡，另一人则完全不见了踪影。
Enterococci are known as the most important multidrug resistant opportunistic pathogens and common cause of hospital-acquired infections.
肠球菌是多重耐药的重要条件致病菌和医院感染常见病原菌。
Occurrence of multidrug resistant strains closely associated with abuse of antibiotics narrowed the clinical option of common antibiotics.
抗生素的滥用导致多重耐药菌株的出现，限制了临床常规抗生素的使用范围。
It is time for countries with rapidly growing economies and a heavy burden of multidrug-resistant tuberculosis to step up their commitment and financing.
对那些经济增长很快并且面临耐多药结核病沉重负担的国家而言，现在到了加强承诺并提供资助的时候了。
In her Ministry office recently, John Donnelly interviewed her about a threat that gives her great concern - the spread of multidrug-resistant TB (MDR-TB).
不久前johnDonnelly在她的办公室里采访了她，内容涉及耐多药结核病蔓延问题，这一威胁令她十分担心。
Lapses in control drive the rise of multidrug-resistant TB, which is far more costly and difficult to treat, and remind us of the constant risk of setbacks.
控制失效导致耐多药结核病病例上升，而此类结核病的治疗要困难许多，也昂贵许多。这提醒我们要时刻牢记挫折风险。
For example, 28% of all people newly diagnosed with TB in one region of north western Russia had the multidrug-resistant form of the disease (MDR-TB) in 2008.
比如在俄罗斯西北部的一个地区，2008年新诊断为结核病的病人当中有28%属耐多药结核病人。
The challenge now is to build on that commitment, to increase the global effort - and to pay particular attention to the growing threat of multidrug-resistant TB.
现在的挑战是以这种承诺为基础，加强全球努力，并且要特别关注多种耐药结核病带来的日益增长的威胁。
Objective: To screen drugs reversing multidrug resistance of tumor cells from active constituents of traditional Chinese medicine and to study the reversal action.
目的：从中药活性成分中筛选肿瘤耐药逆转剂，并对其逆转作用进行研究。
A particularly dangerous form of TB is multidrug-resistant TB (MDR-TB), which is TB that resists at least isoniazid and rifampicin, the two most powerful anti-TB drugs.
特别危险的结核病是多抗药性结核病(multidrug - resistantTB)。这是抗拒至少两种最有效的抗肺结核药——异烟肼和利福平的结核病。
However, there could be worse to come. Nearly 450, 000 new cases of multidrug-resistant tuberculosis are recorded each year; one-third of these people die from the disease.
然而情况可能更加严重，全世界每年新增约45万例多重抗药性肺结核感染的新病例，其中三分之一死于该病。
With the sharp rise of antimicrobial resistance in the world, it is key that research now focuses on antimicrobial resistance and the spread of multidrug resistant pathogens.
随着世界抗菌素耐药性的激增，现在必须着重研究抗菌素耐药性以及多药物耐药性病原体的传播问题。
The threat of returning to a pre-antibiotic era is genuine and probably most vividly illustrated by the rise of multidrug-resistant and extensively drug-resistant tuberculosis.
回到前抗生素时代的威胁是真实的，而耐多药和广泛耐药结核病的增多则是最生动的实例。
Depending on caspase activation, methadone overcomes doxorubicin resistance, multidrug resistance, and apoptosis resistance in leukemia cells through activation of mitochondria.
依赖于半胱氨酸蛋白酶的激活，美沙酮通过激活线粒体克服了白血病细胞中的阿霉素耐药、多药耐药、和凋亡抑制。
The numbers of HIV-positive and multidrug-resistant TB (MDR-TB) patients diagnosed and treated in 2005, although increasing, were far lower than proposed in the Global Plan for 2006.
2005年诊断和治疗的艾滋病毒阳性和耐多药结核患者的人数虽然在增加，但是远低于2006年全球计划中提出的人数。
But now, says the Lancet paper, clinical microbiologists increasingly agree that multidrug-resistant Gram-negative bacteria, which thrive in the gut, pose the greatest risk to public health.
但是该论文指出，现在临床微生物学家日益赞同，活跃于肠道中的多耐药性革兰阴性菌，才对公众健康构成最大威胁。
But now, says the Lancet paper, clinical microbiologists increasingly agree that multidrug-resistant Gram-negative bacteria, which thrive in the gut, pose the greatest risk to public health.
但是该论文指出，现在临床微生物学家日益赞同，活跃于肠道中的多耐药性革兰阴性菌，才对公众健康构成最大威胁。
应用推荐